BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9111592)

  • 21. [Hematologic remission and disappearance of hemolytic anemia in chronic lymphocytic leukemia after therapy with 2-chlorodeoxyadenosine (2-CDA)].
    Piatkowska-Jakubas B; Skotnicki AB
    Acta Haematol Pol; 1993; 24(3):289-93. PubMed ID: 7902636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
    Vick DJ; Byrd JC; Beal CL; Chaffin DJ
    Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
    Robak T; Błasinka-Morawiec M; Krykowski E; Kasznicki M; Płuzanska A; Potemski P; Hellmann A; Zaucha JM; Lewandowski K; Dmoszynska A; Hansz J; Komarnicki M; Konopka L; Durzynski T; Ceglarek B; Sikorska A; Kotlarek-Haus S; Mazur G; Urasinski I; Zdziarska B; Maj S; Kopec I; Skotnicki AB; Dwilewicz-Trojaczek J; Grieb P
    Leuk Lymphoma; 1996 Aug; 22(5-6):509-14. PubMed ID: 8882965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases.
    Kamesaki T; Toyotsuji T; Kajii E
    Am J Hematol; 2013 Feb; 88(2):93-6. PubMed ID: 23169533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of flow cytometry in detection of red-cell-bound IgG in Coombs-negative AIHA.
    Chaudhary R; Das SS; Gupta R; Khetan D
    Hematology; 2006 Aug; 11(4):295-300. PubMed ID: 17178671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
    Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
    Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia.
    Tetreault SA; Saven A
    Leuk Lymphoma; 2000 Mar; 37(1-2):125-30. PubMed ID: 10721776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
    Dearden C; Wade R; Else M; Richards S; Milligan D; Hamblin T; Catovsky D; ; ;
    Blood; 2008 Feb; 111(4):1820-6. PubMed ID: 18055869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin subtyping and quantification in direct antiglobulin test: positive haemolysis in an HIV-prevalent setting.
    Chetty T; Bouwer N; Wan YO; Mahlangu J
    J Clin Pathol; 2022 Feb; 75(2):117-120. PubMed ID: 33328180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
    Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
    Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients.
    Quinquenel A; Al Nawakil C; Baran-Marszak F; Eclache V; Letestu R; Khalloufi M; Boubaya M; Le Roy C; Varin-Blank N; Delmer A; Levy V; Ajchenbaum-Cymbalista F
    Am J Hematol; 2015 Jan; 90(1):E5-8. PubMed ID: 25263543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
    Robak T; Błoński JZ; Urbańska-Ryś H; Błasińska-Morawiec M; Skotnicki AB
    Leukemia; 1999 Apr; 13(4):518-23. PubMed ID: 10214856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
    Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
    Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G; Elmhorn-Rosenborg A; Liliemark J
    N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
    Syed NN; Khurshid M
    J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).
    Delannoy A; Martiat P; Gala JL; Deneys V; Ferrant A; Bosly A; Schieff JM; Michaux JL
    Leukemia; 1995 Jul; 9(7):1130-5. PubMed ID: 7630184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
    Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M
    Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
    Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
    Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.